|
|
|
|
FDA Approves Synthetic Conjugated Oestrogens-A Vaginal Cream for Vulvar, Vaginal Atrophy Symptoms
-- The US Food and Drug Administration (FDA) has approved Synthetic Conjugated Oestrogens-A (SCE-A) 0.625 mg/g Vaginal Cream for the treatment of symptoms related to vulvar and vaginal atrophy including moderate to severe vaginal...
|
|
|
New cream for vaginal dryness approved
Barr Pharmaceuticals, Inc.has announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for Synthetic Conjugated Estrogens-A (SCE-A) 0.625 mg/g...
|
|
|
FDA Approves Duramed's Synthetic Conjugated Estrogens A Vaginal Cream
Barr Pharmaceuticals, Inc.(NYSE: BRL) announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for Synthetic Conjugated Estrogens-A (SCE-A) 0.625...
|
|
|
FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
- First Local Estrogen Therapy Indicated for the Treatment of Both Moderate to Severe Vaginal Dryness and Pain With Intercourse - Symptoms of Vulvar and Vaginal Atrophy Due to Menopause - Further Expands Company's Hormone Therapy...
|
|
|
Synthetic Conjugated Estrogens Vaginal Cream Approved
The FDA has approved Duramed Pharmaceuticals NDA for synthetic conjugated estrogens-A (SCE-A) 0.625 mg/g vaginal cream, indicated for the treatment of moderate to severe vaginal dryness and pain with intercourse (symptoms of vulvar and...
|
|
|
FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
/PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc.today announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for Synthetic Conjugated...
|
|
|
FDA Approves Duramed Pharmaceuticals, Inc. (BRL)'s Synthetic Conjugated Estrogens-A Vaginal Cream
MONTVALE, N.J., Dec.1 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL - News) today announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary 's New Drug Application (NDA) for Synthetic...
|
|
|
FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
- First Local Estrogen Therapy Indicated for the Treatment of Both Moderate to Severe Vaginal Dryness and Pain With Intercourse - Symptoms of Vulvar and Vaginal Atrophy Due to Menopause - Further Expands Company's Hormone Therapy...
|
|
|
FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
/PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc.today announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for Synthetic Conjugated...
|
|
|
Barr Pharma subsidiary receives FDA approval for SCE-A 0.625 mg/g vaginal cream - Update
Generic drug firm Barr Pharmaceuticals Inc.(BRL: News ) announced Monday morning that its subsidiary, Duramed Pharmaceuticals Inc., has received the U.S. Food and Drug Administration or FDA approval for its new drug application or NDA...
|
|
|
MSD India launches Gardasil
Merck Sharp & Dohme (MSD) Pharmaceuticals (India), recently launched Gardasil, a quadrivalent human papilloma virus (HPV) types 6, 11, 16 and 18 vaccine in India.It is the country's first vaccine to help prevent cervical cancer caused...
|
|
|
Cervical Cancer vaccine wins pharma Nobel Prize
GARDASIL, the vaccine used in the New Zealand cervical cancer immunisation programme, has won the prestigious 2008 International Galien Prize, according to Mike Taylor, New Zealand Country Manager for CSL Biotherapies NZ Ltd.An...
|
|
|
FDA Approvals: Premarin, Norditropin, Acanya
Low-Dose CE Cream (Premarin) Approved for Postmenopausal Dyspareunia On November 7, the FDA approved a new indication for a conjugated estrogens (CE) topical vaginal cream (Premarin; Wyeth Pharmaceuticals, Inc), allowing its use for the...
|
|
|
Cytomegalovirus Retinitis in a Monocular Patient
Management options were constrained by poor vision in the fellow eye.CHIRAG P. SHAH, MD, MPH JULIA A. HALLER, MD A 41-year-old female experienced blurred visual acuity in her right eye for several days, associated with fevers and...
|
|
|
FDA Okays Estrogen Cream for Dyspareunia
COLLEGEVILLE, Pa., Nov.14 -- The FDA has approved conjugated estrogen cream (Premarin) to treat dyspareunia under a less-frequent dosing regimen, drug maker Wyeth Pharmaceuticals announced. The 0.5-g dose can be given twice a week to...
|
|
|
Data suggest Merck & Co.'s Gardasil prevents HPV-related disease in boys and men
Late-stage study data presented at the European Research Organization on Genital Infection and Neoplasia conference on Thursday suggest that, compared with placebo, Merck & Co.'s Gardasil prevented 90 percent of external genital...
|
|
|
GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males
WHITEHOUSE STATION, N.J.-- (BUSINESS WIRE) -- GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital...
|
|
|
FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia
COLLEGEVILLE, Pa.-- (BUSINESS WIRE) -- PREMARIN (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S.Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat...
|
|
|
US FDA approves Premarin cream for postmenopausal dyspareunia
Premarin (conjugated estrogens) Vaginal cream 0.5 g has been approved by the US Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal...
|
|
|
New study shows Gardasil reduces HPV-related diseases in men
Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], 'the HPV vaccine', prevented 90 per cent of external genital lesions, including genital warts caused by HPV types 6, 11, 16 and 18 in a phase-III...
|
|
|
FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia
-PREMARIN (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S.Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal...
|
|
|
Merck's HPV Vaccine Gardasil Shows Potential For Men
Merck & Co has presented data on Gardasil which shows that the vaccine, which is approved for cervical cancer, is also effective in the prevention of human papillomavirus-related disease in young men.Data from a Phase III trial in men...
|
|
|
GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males
GARDASIL[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV)...
|
|
|
FDA Approves Low-dose Regimen of Premarin Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia
Agency Grants New Indication for Bothersome Vaginal Symptom Associated With Menopause COLLEGEVILLE, Pa., Nov.13 /PRNewswire-FirstCall/ -- PREMARIN(R) (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug...
|
|
|
Men may also benefit from a vaccine designed to protect women from cervical cancer, researchers said Thursday.
MORE FROM CBC.ca.CBC Kids: play games, get stuff. CBC Local coverage. CBC radio3, Breaking New Sound. CBC Arts and Entertainment CBC.ca | Radio | Television | Local Also on Sympatico / MSN 'Twilight' 101: Who It's About and Why It's...
|
